Warning! GuruFocus detected
5 Severe warning signs
with CBL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Control Bionics Ltd
ISIN : AU0000114183
Share Class Description:
ASX:CBL: Ordinary SharesDescription
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.15 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.54 | |||||
| Beneish M-Score | -3.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.5 | |||||
| 3-Year EBITDA Growth Rate | 13.6 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 16.3 | |||||
| 3-Year Book Growth Rate | -44.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.7 | |||||
| 9-Day RSI | 68.26 | |||||
| 14-Day RSI | 62.03 | |||||
| 3-1 Month Momentum % | -31.75 | |||||
| 6-1 Month Momentum % | -40.28 | |||||
| 12-1 Month Momentum % | 7.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 105.58 | |||||
| Days Sales Outstanding | 123.78 | |||||
| Days Payable | 229.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.1 | |||||
| Shareholder Yield % | -38.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.94 | |||||
| Operating Margin % | -157.7 | |||||
| Net Margin % | -137.22 | |||||
| FCF Margin % | -111.91 | |||||
| ROE % | -101.99 | |||||
| ROA % | -77.77 | |||||
| ROIC % | -124.02 | |||||
| 3-Year ROIIC % | -226.55 | |||||
| ROC (Joel Greenblatt) % | -372.07 | |||||
| ROCE % | -97.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.3 | |||||
| PB Ratio | 2.04 | |||||
| Price-to-Tangible-Book | 5.2 | |||||
| EV-to-EBIT | -2.17 | |||||
| EV-to-EBITDA | -2.55 | |||||
| EV-to-Revenue | 2.92 | |||||
| EV-to-FCF | -2.66 | |||||
| Price-to-GF-Value | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 5.2 | |||||
| Earnings Yield (Greenblatt) % | -46.15 | |||||
| FCF Yield % | -36.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Control Bionics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 5.062 | ||
| EPS (TTM) (A$) | -0.033 | ||
| Beta | 0.93 | ||
| 3-Year Sharpe Ratio | -0.92 | ||
| 3-Year Sortino Ratio | -1.08 | ||
| Volatility % | 64.28 | ||
| 14-Day RSI | 62.03 | ||
| 14-Day ATR (A$) | 0.003118 | ||
| 20-Day SMA (A$) | 0.04255 | ||
| 12-1 Month Momentum % | 7.5 | ||
| 52-Week Range (A$) | 0.034 - 0.105 | ||
| Shares Outstanding (Mil) | 294.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Control Bionics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Control Bionics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Control Bionics Ltd Frequently Asked Questions
What is Control Bionics Ltd(ASX:CBL)'s stock price today?
The current price of ASX:CBL is A$0.05. The 52 week high of ASX:CBL is A$0.11 and 52 week low is A$0.03.
When is next earnings date of Control Bionics Ltd(ASX:CBL)?
The next earnings date of Control Bionics Ltd(ASX:CBL) is .
Does Control Bionics Ltd(ASX:CBL) pay dividends? If so, how much?
Control Bionics Ltd(ASX:CBL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers